NO20081232L - Agarosebelagt, agarosesekretorisk cellekule, samt fremstilling og anvendelse derav - Google Patents

Agarosebelagt, agarosesekretorisk cellekule, samt fremstilling og anvendelse derav

Info

Publication number
NO20081232L
NO20081232L NO20081232A NO20081232A NO20081232L NO 20081232 L NO20081232 L NO 20081232L NO 20081232 A NO20081232 A NO 20081232A NO 20081232 A NO20081232 A NO 20081232A NO 20081232 L NO20081232 L NO 20081232L
Authority
NO
Norway
Prior art keywords
agarose
coated
less
secretory cell
preparation
Prior art date
Application number
NO20081232A
Other languages
English (en)
Other versions
NO341154B1 (no
Inventor
Lawrence Gazda
Barry Smith
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of NO20081232L publication Critical patent/NO20081232L/no
Publication of NO341154B1 publication Critical patent/NO341154B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/76—Agarose, agar-agar

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives fremstilling og anvendelse av kulestrukturer inneholdende sekretoriske celler, som er belagt med agarose. Kulene som fortrinnsvis er 4 mm-12 mm i diameter, og som fortrinnsvis inneholder øyceller, er fremstilt av en spesiell agarose, dvs. Seakem Gold agarose.
NO20081232A 2005-09-26 2008-03-10 Agarosebelagt, agarosesekretorisk cellekule, samt fremstilling og anvendelse derav NO341154B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72091705P 2005-09-26 2005-09-26
PCT/US2006/036125 WO2007038029A2 (en) 2005-09-26 2006-09-14 Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof

Publications (2)

Publication Number Publication Date
NO20081232L true NO20081232L (no) 2008-04-23
NO341154B1 NO341154B1 (no) 2017-09-04

Family

ID=37900243

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081232A NO341154B1 (no) 2005-09-26 2008-03-10 Agarosebelagt, agarosesekretorisk cellekule, samt fremstilling og anvendelse derav

Country Status (18)

Country Link
US (1) US8518394B2 (no)
EP (1) EP1928249B1 (no)
JP (1) JP4937265B2 (no)
KR (1) KR101110386B1 (no)
CN (1) CN101272690B (no)
AT (1) ATE547004T1 (no)
AU (1) AU2006295114B2 (no)
CA (1) CA2622529C (no)
DK (1) DK1928249T3 (no)
ES (1) ES2379008T3 (no)
HK (1) HK1116995A1 (no)
IL (1) IL190028A (no)
NO (1) NO341154B1 (no)
NZ (1) NZ566621A (no)
PL (1) PL1928249T3 (no)
PT (1) PT1928249E (no)
RU (1) RU2417090C2 (no)
WO (1) WO2007038029A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012071394A1 (en) 2010-11-23 2012-05-31 The Rogosin Institute, Inc. Method for isolating a chemotherapeutic agent resistant cancer cell with stem cell properties
BR112014015804B1 (pt) * 2012-01-31 2022-10-18 The Rogosin Institute, Inc Método para produzir uma composição de matéria
US9555007B2 (en) * 2013-03-14 2017-01-31 Massachusetts Institute Of Technology Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983268A (en) * 1989-08-03 1991-01-08 Fmc Corporation High gel strength low electroendosmosis agarose
USRE38027E1 (en) * 1994-01-13 2003-03-11 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
US20050147594A1 (en) * 2003-10-17 2005-07-07 Francois Leblond Semi-permeable microcapsule with covalently linked layers and method for producing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441878A (en) * 1987-12-08 1995-08-15 Thies Technology, Inc. Preparation of uniform droplets by using gas pressure to force liquid from a syringe and flowing gas to detach droplets
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
AU673848B2 (en) * 1992-07-23 1996-11-28 Fmc Corporation Glucomannan spongeous matrices
US5651980A (en) * 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles
US6224912B1 (en) 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US6303151B1 (en) 1996-04-03 2001-10-16 The Rogosin Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US5888497A (en) 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
US6997864B2 (en) 2003-11-03 2006-02-14 Otologics, Llc Method for obtaining diagnostic information relating to a patient having an implanted transducer
JP4704439B2 (ja) * 2004-11-17 2011-06-15 ザ・ロゴシン・インスティテュート 島単離に対する膵臓の適合性を決定するための評価方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983268A (en) * 1989-08-03 1991-01-08 Fmc Corporation High gel strength low electroendosmosis agarose
USRE38027E1 (en) * 1994-01-13 2003-03-11 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
US20050147594A1 (en) * 2003-10-17 2005-07-07 Francois Leblond Semi-permeable microcapsule with covalently linked layers and method for producing same

Also Published As

Publication number Publication date
ATE547004T1 (de) 2012-03-15
EP1928249B1 (en) 2012-02-29
PT1928249E (pt) 2012-05-25
NO341154B1 (no) 2017-09-04
US8518394B2 (en) 2013-08-27
AU2006295114A1 (en) 2007-04-05
EP1928249A4 (en) 2010-04-07
EP1928249A2 (en) 2008-06-11
PL1928249T3 (pl) 2012-11-30
DK1928249T3 (da) 2012-06-18
AU2006295114B2 (en) 2010-01-28
CA2622529C (en) 2014-02-18
JP4937265B2 (ja) 2012-05-23
RU2008114920A (ru) 2009-11-10
JP2009509507A (ja) 2009-03-12
KR20080071122A (ko) 2008-08-01
WO2007038029A3 (en) 2007-09-20
ES2379008T3 (es) 2012-04-19
CN101272690A (zh) 2008-09-24
KR101110386B1 (ko) 2012-03-08
WO2007038029A2 (en) 2007-04-05
US20070071732A1 (en) 2007-03-29
CA2622529A1 (en) 2007-04-05
IL190028A0 (en) 2008-08-07
HK1116995A1 (en) 2009-01-09
CN101272690B (zh) 2012-08-29
IL190028A (en) 2014-12-31
RU2417090C2 (ru) 2011-04-27
NZ566621A (en) 2010-07-30

Similar Documents

Publication Publication Date Title
WO2006055689A3 (en) Protein scaffolds and uses thereof
SG196839A1 (en) Antibodies against fcrn and use thereof
ATE535547T1 (de) Vernetzte antikörper
PT2298287T (pt) Composições estabilizadas de polipéptidos de fator vii
CY1110877T1 (el) Αλλαγη των συγγενειων συνδεσης me fcrn ή των ημιζωων ορου αντισωματων με μεταλλαξιγενεση
NO20065084L (no) Interferon-alfa polypeptider og konjugater
EA200700042A1 (ru) РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
ES2570760T3 (es) Biogel
WO2004061080A3 (en) Stress-related polypeptides and uses therefor
BRPI0617788A2 (pt) processos isolados estaticamente verificáveis com comunicação interprocessos
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
WO2007011857A3 (en) Low pungency, long day onion
WO2018052464A8 (en) METHODS AND SYSTEMS FOR MULTIPLEX TESTING
WO2007052102A3 (en) Modified green fluorescent proteins and methods for using same
CY1110381T1 (el) Πεπτιδια χ-κωνοτοξινης ως αναστολεις των νευρωνικων αμινικων μεταφορεων
BR0312521A (pt) Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado
NO20081232L (no) Agarosebelagt, agarosesekretorisk cellekule, samt fremstilling og anvendelse derav
HRP20041088A2 (en) Method for identifying and extracing endotoxin
ATE323739T1 (de) Stabilisatorzusammensetzung für halogenierte polymere, deren verwendung und solche zusammensetzungen enthaltende polymere
DK1226097T3 (da) Syntetisk silikatkugle-sammensætning og fremgangsmåde og anvendelse deraf
WO2002083932A3 (de) Enzymabbauketten
MX2021007028A (es) Anticuerpo anti-il-17a y uso del mismo.
EP2098594A4 (en) NUCLEIC ACID MOLECULE CAPABLE OF BINDING A BIT-DARNED IGG ANTIBODY
CY1118533T1 (el) Μεθοδος χρωματογραφιας συναφειας αντιδρομβινης iii
ATE496133T1 (de) Affinitätspolypeptid zur reinigung von rekombinanten proteinen

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THE ROGOSIN INSTITUTE, US

MM1K Lapsed by not paying the annual fees